Title | Creator | Description | Identifier | ||
---|---|---|---|---|---|
1 | What Have We Learned From the Idiopathic Intracranial Hypertension Treatment Trial | Michael Wall | Importance: Acetazolamide is commonly used to treat idiopathic intracranial hypertension (IIH) but there is insufficient information to establish an evidence base for its use. Objective: To determine whether acetazolamide is beneficial in improving vision when added to a low sodium, weight reduction... | 20150225_nanos_hottopic2_01-1 | |
2 | What Have We Learned From the Idiopathic Intracranial Hypertension Treatment Trial | Michael Wall, MD, University of Iowa, Department of Neurology and Ophthalmology | Acetazolamide is commonly used to treat idiopathic intracranial hypertension (IIH) but there is insufficient information to establish an evidence base for its use.Objective: To determine whether acetazolamide is beneficial in improving vision when added to a low sodium, weight reduction diet in IIH ... | 20150225_nanos_hottopic2_01 |